Cormorant Asset Management, LP Pharvaris N.V. Transaction History
Cormorant Asset Management, LP
- $1.74 Billion
- Q1 2024
A detailed history of Cormorant Asset Management, LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,711,460 shares of PHVS stock, worth $32.2 Million. This represents 2.28% of its overall portfolio holdings.
Number of Shares
1,711,460
Previous 1,711,460
-0.0%
Holding current value
$32.2 Million
Previous $48 Million
17.61%
% of portfolio
2.28%
Previous 2.89%
Shares
10 transactions
Others Institutions Holding PHVS
# of Institutions
35Shares Held
37.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$142 Million4.07% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$80.6 Million38.74% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.04MShares$75.9 Million47.16% of portfolio
-
Viking Global Investors LP3.65MShares$68.7 Million0.32% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$63.8 Million6.74% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $635M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...